Managing Director - Investments
Rich has over 30 years of professional experience in public and private finance, executive management and operations, and for the past nine has been exclusively involved in the cannabis industry. Rich is a Managing Director of Tuatara Capital. At Tuatara, Richard works with the senior partners to source, evaluate and monitor investments across Tuatara’s target areas of focus in the cannabis industry. Prior to joining Tuatara, Rich was the Co-Founder, President and Chief Executive Officer of Curaleaf, Inc. (CNSX: CURA, formerly known as PalliaTech, Inc.), which is a national cannabis company founded in 2009 with the mission of unlocking the therapeutic potential of cannabis. Curaleaf, Inc. currently produces and dispenses cannabinoid-based medicines in twelve states.
Before joining Curaleaf, Richard was the President and Chief Executive Officer of Delcath Systems, Inc. (NASDAQ: DCTH), a medical technology company that developed a patented system for the targeted delivery of ultra-high dose chemotherapy to the liver for treatment of a variety of cancers. Under his leadership, Delcath enrolled a Phase III clinical trial, obtained two Orphan Drug Designations from the U.S. Food and Drug Administration, and expanded the Company’s activities into China, Europe and Japan.
Prior to leading Delcath, Rich served as Chairman of the Board of Directors of MGT Capital Investments, Inc. (AMEX: MGT), a medical technology company engaged in the development and commercialization of computer-aided detection applications that analyze computer tomography (CT) scans to assist radiologists in the early detection and measurement of colorectal polyps and lung lesions.
Previously, Rich was the founding member of T2 Capital Management, LLC, an investment management company, and Sandpiper Capital Partners, a private equity firm focused on companies involved in a variety of emerging technologies. Earlier in his career, Rich spent over 20 years advising institutional and high net worth clients at Salomon Brothers, Goldman Sachs, Merrill Lynch and Banc of America Securities. Richard earned a Bachelor of Arts degree from Tufts University and a Juris Doctor from the Temple University School of Law.